Synthesis, Biological Evaluation, and In Silico Studies of Naphtalene‐Hydrazide Derivatives as Dual‐Action Agents for Alzheimer's Disease: Targeting BChE and Oxidative Stress
Interestingly, compounds 7a and 8a exhibited five‐fold higher selectivity for BChE than AChE, suggesting their potential relevance for further exploration in the context of Alzheimer's disease therapeutics.
Abstract
In this study, the ChE inhibitory effects and antioxidant capacities of newly synthesized naphthohydrazide derivatives (
4a–9a
) are reported, along with molecular docking and molecular dynamics (MD) simulation results. In enzyme inhibition studies, the synthesized compounds displayed distinct selectivity toward BChE; derivatives
6a, 7a,
and
8a
(IC
50
: 21.50–22.63 µM) showed strong BChE inhibition, which was closely comparable to that of the reference drug galantamine. In antioxidant assays, compound
7a
exhibited exceptional potency in the ABTS radical scavenging assay (IC
50
= 0.04 µM), significantly outperforming the standard reference. SAR analysis indicated that
7a
offered an excellent steric fit for the expanded BChE active site, while the bromine atom in
8a
established van der Waals interactions within the hydrophobic region, yielding a 5‐fold selectivity for BChE over AChE. Molecular docking further revealed that
7a
achieved the lowest binding energies against both AChE (−11.3 kcal/mol) and BChE (−9.4 kcal/mol), forming key interactions with peripheral site residues (Ser125 and Tyr337 of AChE; Ile69 and Thr120 of BChE) and the catalytic triad residue His438 of BChE. Notably, compounds
7a
and
8a
exhibited five‐fold higher selectivity for BChE than AChE, suggesting their potential relevance for further exploration in the context of Alzheimer's disease therapeutics.
The results indicate that the thiazole-benzodioxole scaffold is a promising framework for developing multifunctional agents with combined neuroprotective, antidiabetic, and antioxidant activities.
Tuğçe Çaklılı, Yusuf Sıcak, Somdatta Y. Chaudhari et al.· Pharmaceuticals· 0 citations
Compound 17v represents a promising lead compound for anti-Alzheimer's therapy and may possess multi-target neuroprotective potential and a favorable preliminary safety profile, supporting its further investigation as a potential therapeutic candidate for Alzheimer’s disease.
Yi-Xuan Wang, Shi-Hao Qin, Qiang Liu et al.· Medicinal Chemistry Research· 0 citations
Findings highlight the potential of benzisothiazole‐based hydrazide derivatives as promising scaffolds for the development of new antitubercular agents and suggest InhA as a potential molecular target.
V. Sharma, Arun Sharma, Ruchi Poria et al.· Chemical Biology and Drug De...· 0 citations
The determined biological activities of Schiff base derivatives obtained from 4-aminoantipyrine via condensation with various aromatic and heteroaromatic aldehydes support these derivatives as promising multifunctional scaffolds for the development of novel antibacterial and anticancer agents.
M. I. Sultan, Muthanna C. Urabee, A. Sadiq et al.· Journal of Genetic Engineeri...· 0 citations
Findings identify trimetazidine‐derived hydrazide‐hydrazones as a promising chemotype for the development of selective AChE inhibitors and provide a basis for further optimization and advanced biological validation.
Muhammed Oğuzhan Doğan, B. Özkan, A. Karaduman et al.· Drug development research (P...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.